210 related articles for article (PubMed ID: 26879328)
1. Azilsartan, an angiotensin II type 1 receptor blocker, attenuates tert-butyl hydroperoxide-induced endothelial cell injury through inhibition of mitochondrial dysfunction and anti-inflammatory activity.
Liu H; Mao P; Wang J; Wang T; Xie CH
Neurochem Int; 2016 Mar; 94():48-56. PubMed ID: 26879328
[TBL] [Abstract][Full Text] [Related]
2. Jatrorrhizine Hydrochloride alleviates tert-butyl hydroperoxide-induced endothelial cell injury through its anti-inflammatory activity and PPAR-γ activation.
Wu G; Mu T; Zhang L; Chen X
Cell Mol Biol (Noisy-le-grand); 2020 May; 66(2):125-129. PubMed ID: 32415938
[TBL] [Abstract][Full Text] [Related]
3. Nitroglycerin-induced endothelial dysfunction and tolerance involve adverse phosphorylation and S-Glutathionylation of endothelial nitric oxide synthase: beneficial effects of therapy with the AT1 receptor blocker telmisartan.
Knorr M; Hausding M; Kröller-Schuhmacher S; Steven S; Oelze M; Heeren T; Scholz A; Gori T; Wenzel P; Schulz E; Daiber A; Münzel T
Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2223-31. PubMed ID: 21757654
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of Homer1 attenuates t-BHP-induced oxidative stress through regulating calcium homeostasis and ER stress in brain endothelial cells.
Guo ZY; Zhang YH; Xie GQ; Liu CX; Zhou R; Shi W
Biochem Biophys Res Commun; 2016 Sep; 477(4):970-976. PubMed ID: 27396622
[TBL] [Abstract][Full Text] [Related]
5. Azilsartan, an angiotensin II type 1 receptor blocker, restores endothelial function by reducing vascular inflammation and by increasing the phosphorylation ratio Ser(1177)/Thr(497) of endothelial nitric oxide synthase in diabetic mice.
Matsumoto S; Shimabukuro M; Fukuda D; Soeki T; Yamakawa K; Masuzaki H; Sata M
Cardiovasc Diabetol; 2014 Jan; 13():30. PubMed ID: 24485356
[TBL] [Abstract][Full Text] [Related]
6. Molecular and cellular effects of azilsartan: a new generation angiotensin II receptor blocker.
Kajiya T; Ho C; Wang J; Vilardi R; Kurtz TW
J Hypertens; 2011 Dec; 29(12):2476-83. PubMed ID: 21986624
[TBL] [Abstract][Full Text] [Related]
7. Protective mechanisms of the angiotensin II type 1 receptor blocker candesartan against cerebral ischemia: in-vivo and in-vitro studies.
Liu H; Kitazato KT; Uno M; Yagi K; Kanematsu Y; Tamura T; Tada Y; Kinouchi T; Nagahiro S
J Hypertens; 2008 Jul; 26(7):1435-45. PubMed ID: 18551021
[TBL] [Abstract][Full Text] [Related]
8. Salvianic acid A sodium protects HUVEC cells against tert-butyl hydroperoxide induced oxidative injury via mitochondria-dependent pathway.
Jia D; Li T; Chen X; Ding X; Chai Y; Chen AF; Zhu Z; Zhang C
Chem Biol Interact; 2018 Jan; 279():234-242. PubMed ID: 29128606
[TBL] [Abstract][Full Text] [Related]
9. Novel angiotensin receptor blocker, azilsartan induces oxidative stress and NFkB-mediated apoptosis in hepatocellular carcinoma cell line HepG2.
Ahmadian E; Khosroushahi AY; Eftekhari A; Farajnia S; Babaei H; Eghbal MA
Biomed Pharmacother; 2018 Mar; 99():939-946. PubMed ID: 29710494
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II type 1 receptor blockers prevent tumor necrosis factor-alpha-mediated endothelial nitric oxide synthase reduction and superoxide production in human umbilical vein endothelial cells.
Kataoka H; Murakami R; Numaguchi Y; Okumura K; Murohara T
Eur J Pharmacol; 2010 Jun; 636(1-3):36-41. PubMed ID: 20353766
[TBL] [Abstract][Full Text] [Related]
11. Ability of the new AT1 receptor blocker azilsartan to block angiotensin II-induced AT1 receptor activation after wash-out.
Miura S; Matsuo Y; Nakayama A; Tomita S; Suematsu Y; Saku K
J Renin Angiotensin Aldosterone Syst; 2014 Mar; 15(1):7-12. PubMed ID: 23563275
[TBL] [Abstract][Full Text] [Related]
12. Role of angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis in the hypotensive effect of azilsartan.
Iwanami J; Mogi M; Tsukuda K; Wang XL; Nakaoka H; Ohshima K; Chisaka T; Bai HY; Kanno H; Min LJ; Horiuchi M
Hypertens Res; 2014 Jul; 37(7):616-20. PubMed ID: 24599018
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol regulates mitochondrial reactive oxygen species homeostasis through Sirt3 signaling pathway in human vascular endothelial cells.
Zhou X; Chen M; Zeng X; Yang J; Deng H; Yi L; Mi MT
Cell Death Dis; 2014 Dec; 5(12):e1576. PubMed ID: 25522270
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive, insulin-sensitising and renoprotective effects of a novel, potent and long-acting angiotensin II type 1 receptor blocker, azilsartan medoxomil, in rat and dog models.
Kusumoto K; Igata H; Ojima M; Tsuboi A; Imanishi M; Yamaguchi F; Sakamoto H; Kuroita T; Kawaguchi N; Nishigaki N; Nagaya H
Eur J Pharmacol; 2011 Nov; 669(1-3):84-93. PubMed ID: 21816148
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin II Type 1 Receptor Antagonist Azilsartan Restores Vascular Reactivity Through a Perivascular Adipose Tissue-Independent Mechanism in Rats with Metabolic Syndrome.
Kagota S; Maruyama-Fumoto K; Shimari M; McGuire JJ; Shinozuka K
Cardiovasc Drugs Ther; 2019 Oct; 33(5):501-509. PubMed ID: 31420755
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective potential of azilsartan against cerebral ischemic injury: Possible involvement of mitochondrial mechanisms.
Gupta V; Dhull DK; Joshi J; Kaur S; Kumar A
Neurochem Int; 2020 Jan; 132():104604. PubMed ID: 31751621
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory and anti-oxidant properties of telmisartan in cultured human umbilical vein endothelial cells.
Cianchetti S; Del Fiorentino A; Colognato R; Di Stefano R; Franzoni F; Pedrinelli R
Atherosclerosis; 2008 May; 198(1):22-8. PubMed ID: 17950296
[TBL] [Abstract][Full Text] [Related]
18. Cardioprotective effects of azilsartan compared with that of telmisartan on an in vivo model of myocardial ischemia-reperfusion injury.
Garg S; Khan SI; Malhotra RK; Sharma MK; Kumar M; Kaur P; Nag TC; Ray R; Bhatia J; Arya DS
J Biochem Mol Toxicol; 2021 Jul; 35(7):e22785. PubMed ID: 33860986
[TBL] [Abstract][Full Text] [Related]
19. Telmisartan inhibits vasoconstriction via PPARγ-dependent expression and activation of endothelial nitric oxide synthase.
Yuen CY; Wong WT; Tian XY; Wong SL; Lau CW; Yu J; Tomlinson B; Yao X; Huang Y
Cardiovasc Res; 2011 Apr; 90(1):122-9. PubMed ID: 21156825
[TBL] [Abstract][Full Text] [Related]
20. Berberine attenuated the cytotoxicity induced by t-BHP via inhibiting oxidative stress and mitochondria dysfunction in PC-12 cells.
Li Z; Jiang T; Lu Q; Xu K; He J; Xie L; Chen Z; Zheng Z; Ye L; Xu K; Zhang H; Hu A
Cell Mol Neurobiol; 2020 May; 40(4):587-602. PubMed ID: 31828466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
